I had posed a number of questions on DRGP's Yahoo Message board and received this answer.
"Here is the way I see the quarterly on your questions:
1) No - heavy loss due to substantial increase in expenses
2) Addtl shares - 4.45m + 2.3 - 3 mil more to Melissa Rice at the current stock price
3) Yes - positive cash flow
4) 10 products declined, 6 in various testing stages + submission to Medicare for the Medico line.
5) No guidance stated in the report. This would need to come from a CC, but does not appear there will be one, which is there normal MO."
To this I replied.
One clarification....
The number of shares outstanding have stayed the same since the May 15, 2008 10Q and I quote from front page:
"The number of shares outstanding of each of the issuer’s classes of common equity, as of May 14, 2008 was 90,548,066 shares."
From yesterday's 10Q,
"As of July 31, 2008, there were 90,548,066 shares of common stock issued and outstanding."
I think that this is good indication. DRGP is not a typical pinkie diluting machine. It is clear that CEO Melissa Rice has turned off the spigot and there are only so many shares available shares to be bought or sold.
I continue to believe that IF THE COMPANY CONTINUES GROWING...we will eventually see some long term appreciation.
